Alcedis Revenue and Competitors
Estimated Revenue & Valuation
- Alcedis's estimated annual revenue is currently $12.4M per year.
- Alcedis's estimated revenue per employee is $102,000
Employee Data
- Alcedis has 122 Employees.
- Alcedis grew their employee count by 4% last year.
Alcedis's People
Name | Title | Email/Phone |
---|
Alcedis Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13M | 127 | 43% | N/A | N/A |
#2 | $11.2M | 110 | 62% | N/A | N/A |
#3 | $27.3M | 243 | 10% | N/A | N/A |
#4 | $26M | 237 | 25% | $11M | N/A |
#5 | $3.3M | 41 | -11% | N/A | N/A |
#6 | $11.6M | 114 | 24% | N/A | N/A |
#7 | $1.6M | 22 | 5% | N/A | N/A |
#8 | $34.9M | 548 | 18% | N/A | N/A |
#9 | $50.2M | 394 | -5% | N/A | N/A |
#10 | $13.6M | 243 | -10% | N/A | N/A |
What Is Alcedis?
Alcedis is a globally acting CRO market-leader for data driven clinical research and technology utilization. Our module-based service concept adjusts itself flexibly to your project structure. Likewise individually adapted are our data entry and software systems.
keywords:N/AN/A
Total Funding
122
Number of Employees
$12.4M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Alcedis News
2022-04-13 - Mainz Biomed Announces First Quarter 2022 Results | Your ...
Sentinel Diagnostics is a global leader in the development and production of in vitro diagnostics (IVD), and Alcedis GmbH is a full-service...
2022-03-22 - Mainz Biomed Appoints Key Clinical Trial Partners for ColoFuture Study
Leading Clinical Research Organization Alcedis Selected to Manage the Study. - ColoFuture on track to complete enrollment in 2H 2022 -.